Ardent Health financials
$10.58+1.05%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $6.32B | $5.97B |
| Gross profit | $6.32B | $5.97B |
| Gross margin | 100.0% | 100.0% |
| Operating income | $325.6M | $405.8M |
| Net income | $135.8M | $210.3M |
| Net margin | 2.1% | 3.5% |
| Diluted EPS | $0.96 | $1.58 |
| EBITDA | $481.3M | $552.0M |
| Operating cash flow | $470.5M | $315.0M |
| Free cash flow | $258.6M | $127.5M |
| Diluted shares | 141.5M | 132.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $709.6M | $556.8M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $1.10B | $1.10B |
| Total assets | $5.29B | $4.96B |
| Total liabilities | $3.61B | $3.43B |
| Shareholders' equity | $1.69B | $1.52B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology